Jaeseong Oh (J Oh)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 67

Top Topics

Antiplatelet Therapy

Top Venues

Clinical and translational science

Translational and clinical pharmacology

Experimental & molecular medicine

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Yoonjin Kim, Sungyeun Bae, Ki Young Huh, Jong Sun Joo, Jikyo Lee, Sang Hoon Song, Kyung-Sang Yu, In-Jin Jang, Jaeseong Oh
Coadministration of Voriconazole and Rifabutin Can Increase the Risk of Adverse Drug Reactions in Patients with Multiple Infections. Therapeutic drug monitoring (2024)
Xu Jiang, Kyung-Sang Yu, Dong Hyuk Nam, Jaeseong Oh
A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Juyoung Khwarg, Soyoung Lee, In-Jin Jang, Won-Ho Kang, Hye Jung Lee, Kyu Yeon Kim, Ki-Sun Jeong, Chongho Won, Youn Woong Choi, Dae Chul Ha, RaeHoon Jung, Min-Gu Han, Won Tae Jung, Kyu-Yeol Nam, YeSeul Kim, Kyung-Sang Yu, Jaeseong Oh
Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Omega-3-Acid Ethyl Esters and the Corresponding Loose Combination in Healthy Korean Male Subjects. Drug design, development and therapy 18 (2024)
Jihoon G Yoon, Dong Geon Jang, Sung-Gyu Cho, Chaeyoung Lee, Shin Hye Noh, Soo Kyung Seo, Jung Woo Yu, Hyeon Woo Chung, KyeoRe Han, Soon Sung Kwon, Dai Hoon Han, Jaeseong Oh, In-Jin Jang, Sang-Hoon Kim, Young-Koo Jee, Hyun Lee, Dong Won Park, Tae-Hyung Kim, Ho Joo Yoon, Chul Hoon Kim, Jae Myun Lee, Sang-Heon Kim, Min Goo Lee
Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity. Experimental & molecular medicine 56 (3) (2024)
Byungwook Kim, Joo-Youn Cho, Ildae Song, Jaeseong Oh
Pharmacogenetic Analysis of an 8-Year Old Girl with Reye Syndrome Associated with Use of Naproxen. The American journal of case reports 25 (2024)
Heejae Won, Deok Yong Yoon, Sangmi Lee, Joo-Youn Cho, Jaeseong Oh, In-Jin Jang, Sang-Ku Yoo, Kyung-Sang Yu
Effects of meal type on the bioavailability of vutiglabridin, a novel anti-obesity agent, in healthy subjects. Clinical and translational science 17 (3) (2024)
Byungwook Kim, Joo-Youn Cho, Ildae Song, Jaeseong Oh
Pharmacogenetic Analysis of an 8-Year Old Girl with Reye Syndrome Associated with Use of Naproxen. The American journal of case reports 25 (2024)
Jihoon G Yoon, Dong Geon Jang, Sung-Gyu Cho, Chaeyoung Lee, Shin Hye Noh, Soo Kyung Seo, Jung Woo Yu, Hyeon Woo Chung, KyeoRe Han, Soon Sung Kwon, Dai Hoon Han, Jaeseong Oh, In-Jin Jang, Sang-Hoon Kim, Young-Koo Jee, Hyun Lee, Dong Won Park, Tae-Hyung Kim, Ho Joo Yoon, Chul Hoon Kim, Jae Myun Lee, Sang-Heon Kim, Min Goo Lee
Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity. Experimental & molecular medicine 56 (3) (2024)
Hyunwook Ryu, Hyun Chul Kim, Inseung Jeon, In-Jin Jang, Joo-Youn Cho, Kyung Tae Kim, Jaeseong Oh
Pharmacokinetic Interactions Between the Fixed-Dose Combination of Ezetimibe/Rosuvastatin 10/20 Mg and the Fixed-Dose Combination of Telmisartan/Amlodipine 80/5 Mg in Healthy Subjects. Drug design, development and therapy 18 (2024)
Heejae Won, Deok Yong Yoon, Sangmi Lee, Joo-Youn Cho, Jaeseong Oh, In-Jin Jang, Sang-Ku Yoo, Kyung-Sang Yu
Effects of meal type on the bioavailability of vutiglabridin, a novel anti-obesity agent, in healthy subjects. Clinical and translational science 17 (3) (2024)
Jihoon G Yoon, Dong Geon Jang, Sung-Gyu Cho, Chaeyoung Lee, Shin Hye Noh, Soo Kyung Seo, Jung Woo Yu, Hyeon Woo Chung, KyeoRe Han, Soon Sung Kwon, Dai Hoon Han, Jaeseong Oh, In-Jin Jang, Sang-Hoon Kim, Young-Koo Jee, Hyun Lee, Dong Won Park, Tae-Hyung Kim, Ho Joo Yoon, Chul Hoon Kim, Jae Myun Lee, Sang-Heon Kim, Min Goo Lee
Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity. Experimental & molecular medicine 56 (3) (2024)
Jihoon G Yoon, Dong Geon Jang, Sung-Gyu Cho, Chaeyoung Lee, Shin Hye Noh, Soo Kyung Seo, Jung Woo Yu, Hyeon Woo Chung, KyeoRe Han, Soon Sung Kwon, Dai Hoon Han, Jaeseong Oh, In-Jin Jang, Sang-Hoon Kim, Young-Koo Jee, Hyun Lee, Dong Won Park, Tae-Hyung Kim, Ho Joo Yoon, Chul Hoon Kim, Jae Myun Lee, Sang-Heon Kim, Min Goo Lee
Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity. Experimental & molecular medicine (2024)
Juyoung Khwarg, Soyoung Lee, In-Jin Jang, Won-Ho Kang, Hye Jung Lee, Kyu Yeon Kim, Ki-Sun Jeong, Chongho Won, Youn Woong Choi, Dae Chul Ha, RaeHoon Jung, Min-Gu Han, Won Tae Jung, Kyu-Yeol Nam, YeSeul Kim, Kyung-Sang Yu, Jaeseong Oh
Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Omega-3-Acid Ethyl Esters and the Corresponding Loose Combination in Healthy Korean Male Subjects. Drug design, development and therapy 18 (2024)
Xu Jiang, Kyung-Sang Yu, Dong Hyuk Nam, Jaeseong Oh
A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Heejae Won, Deok Yong Yoon, Sangmi Lee, Joo-Youn Cho, Jaeseong Oh, In-Jin Jang, Sang-Ku Yoo, Kyung-Sang Yu
Effects of meal type on the bioavailability of vutiglabridin, a novel anti-obesity agent, in healthy subjects. Clinical and translational science 17 (3) (2024)
Byungwook Kim, Joo-Youn Cho, Ildae Song, Jaeseong Oh
Pharmacogenetic Analysis of an 8-Year Old Girl with Reye Syndrome Associated with Use of Naproxen. The American journal of case reports 25 (2024)
Woo Kyung Chung, Ki Young Huh, Jiyeon Park, Jaeseong Oh, Kyung-Sang Yu
Establishment of Advanced Regulatory Innovation for Clinical Trials Transformation (ARICTT): a multi-stakeholder public-private partnership-based organization to accelerate the transformation of clinical trials. Translational and clinical pharmacology 32 (1) (2024)
Byungwook Kim, Joo-Youn Cho, Ildae Song, Jaeseong Oh
Pharmacogenetic Analysis of an 8-Year Old Girl with Reye Syndrome Associated with Use of Naproxen. The American journal of case reports 25 (2024)
Woo Kyung Chung, Ki Young Huh, Jiyeon Park, Jaeseong Oh, Kyung-Sang Yu
Establishment of Advanced Regulatory Innovation for Clinical Trials Transformation (ARICTT): a multi-stakeholder public-private partnership-based organization to accelerate the transformation of clinical trials. Translational and clinical pharmacology 32 (1) (2024)
Jihoon G Yoon, Dong Geon Jang, Sung-Gyu Cho, Chaeyoung Lee, Shin Hye Noh, Soo Kyung Seo, Jung Woo Yu, Hyeon Woo Chung, KyeoRe Han, Soon Sung Kwon, Dai Hoon Han, Jaeseong Oh, In-Jin Jang, Sang-Hoon Kim, Young-Koo Jee, Hyun Lee, Dong Won Park, Tae-Hyung Kim, Ho Joo Yoon, Chul Hoon Kim, Jae Myun Lee, Sang-Heon Kim, Min Goo Lee
Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity. Experimental & molecular medicine 56 (3) (2024)
Hyunwook Ryu, Hyun Chul Kim, Inseung Jeon, In-Jin Jang, Joo-Youn Cho, Kyung Tae Kim, Jaeseong Oh
Pharmacokinetic Interactions Between the Fixed-Dose Combination of Ezetimibe/Rosuvastatin 10/20 Mg and the Fixed-Dose Combination of Telmisartan/Amlodipine 80/5 Mg in Healthy Subjects. Drug design, development and therapy 18 (2024)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs 42 (1) (2023)
Xu Jiang, Sungyeun Bae, Deok Yong Yoon, Shin Jung Park, Jaeseong Oh, Joo-Youn Cho, Kyung-Sang Yu
Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects. Drug design, development and therapy 17 (2023)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs 42 (1) (2023)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs (2023)
Bo Rim Kim, Leerang Lim, YoungRok Choi, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Kyung-Sang Yu, Jin Young Sohn, Raewon Jeong, Jaeseong Oh, Ho Geol Ryu
Continuous versus Intermittent Infusion of Human Antithrombin III Concentrate in the Immediate Postoperative Period after Liver Transplantation. Clinical and translational science (2023)
JungJin Oh, Eunsol Yang, In-Jin Jang, Hyejung Lee, Hokyun Yoo, Jae-Yong Chung, SeungHwan Lee, Jaeseong Oh
Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects. Pharmaceutics 15 (2) (2023)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs 42 (1) (2023)
Ki Young Huh, Woo Kyung Chung, Jiyeon Park, Seung Hwan Lee, Min Gul Kim, Jaeseong Oh, Kyung-Sang Yu
Feasibility study for a fully decentralized clinical trial in participants with functional constipation symptoms. Clinical and translational science (2023)
Hyunjoon Lee, Sejung Hwang, In-Jin Jang, Jae-Young Chung, Jaeseong Oh
Adaptive design clinical trials: current status by disease and trial phase in various perspectives. Translational and clinical pharmacology 31 (4) (2023)
Min Young Park, Sungyeun Bae, Jung A Heo, Mihee Park, YuKyung Kim, Jumi Han, In-Jin Jang, Kyung-Sang Yu, Jaeseong Oh
Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl-tRNA synthetase inhibitor, in healthy subjects. Clinical and translational science (2023)
Seolah Lee, Hyun Chul Kim, Yoonhyuk Jang, Han Sang Lee, Seon-Jae Ahn, Soon Tae Lee, Keun Hwa Jung, Kyung-Il Park, Ki-Young Jung, Jaeseong Oh, Seung Hwan Lee, Kyung-Sang Yu, In-Jin Jang, Soyoung Lee, Kon Chu, Sang Kun Lee
Topiramate dosage optimization for effective antiseizure management via population pharmacokinetic modeling. Annals of clinical and translational neurology (2023)
Min Young Park, Sungyeun Bae, Jung A Heo, Mihee Park, YuKyung Kim, Jumi Han, In-Jin Jang, Kyung-Sang Yu, Jaeseong Oh
Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl-tRNA synthetase inhibitor, in healthy subjects. Clinical and translational science (2023)
Soyoung Lee, Kyung Taek Hong, In-Jin Jang, Kyung-Sang Yu, Hyoung Jin Kang, Jaeseong Oh
Semimechanistic pharmacokinetic-pharmacodynamic model of tripegfilgrastim for pediatric patients after chemotherapy. CPT: pharmacometrics & systems pharmacology (2023)
Sungyeun Bae, Ki Young Huh, Jaeseong Oh, Kyung-Sang Yu, Anhye Kim
Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
JungJin Oh, Eunsol Yang, In-Jin Jang, Hyejung Lee, Hokyun Yoo, Jae-Yong Chung, SeungHwan Lee, Jaeseong Oh
Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects. Pharmaceutics 15 (2) (2023)
Hyunjoon Lee, Sejung Hwang, In-Jin Jang, Jae-Young Chung, Jaeseong Oh
Adaptive design clinical trials: current status by disease and trial phase in various perspectives. Translational and clinical pharmacology 31 (4) (2023)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs 42 (1) (2023)
Sungyeun Bae, Ki Young Huh, Jaeseong Oh, Kyung-Sang Yu, Anhye Kim
Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Min Young Park, Sungyeun Bae, Jung A Heo, Mihee Park, YuKyung Kim, Jumi Han, In-Jin Jang, Kyung-Sang Yu, Jaeseong Oh
Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl-tRNA synthetase inhibitor, in healthy subjects. Clinical and translational science (2023)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs 42 (1) (2023)
JungJin Oh, Eunsol Yang, In-Jin Jang, Hyejung Lee, Hokyun Yoo, Jae-Yong Chung, SeungHwan Lee, Jaeseong Oh
Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects. Pharmaceutics 15 (2) (2023)
Woo Kyung Chung, Inyoung Hwang, Byungwook Kim, Jihyun Jung, Kyung-Sang Yu, In-Jin Jang, Jaeseong Oh
Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers. Clinical and translational science 16 (3) (2022)
Sohyun Park, Youn Woo Lee, Jaeseong Oh, Su Jin Kim, Sukmook Lee, Ho-Young Lee
Pharmacokinetic evaluation of radiolabeled intraocular anti-CLEC14a antibody in preclinical animal species and application in humans. Clinical and translational science (2022)
Jun Gi Hwang, Seung Hwan Lee, Wan Huh, Jumi Han, Jaeseong Oh, In-Jin Jang, Kyung-Sang Yu
Dose-dependent glucosuria of DWP16001, a novel selective sodium-glucose cotransporter-2 inhibitor, in healthy subjects. British journal of clinical pharmacology 88 (9) (2022)
Woo Kyung Chung, Inyoung Hwang, Byungwook Kim, Jihyun Jung, Kyung-Sang Yu, In-Jin Jang, Jaeseong Oh
Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers. Clinical and translational science 16 (3) (2022)
Sae Im Jeong, Heejae Won, Ildae Song, Jaeseong Oh
Therapeutic drug monitoring on the use of transplacental digoxin in fetal tachyarrhythmia: a case report. Translational and clinical pharmacology 30 (2) (2022)
Jeongeun Lee, Jean Lee, Sungwon Jeon, Jeongha Lee, Insu Jang, Jin Ok Yang, Soojin Park, Byungwook Lee, Jinwook Choi, Byung-Ok Choi, Heon Yung Gee, Jaeseong Oh, In-Jin Jang, Sanghyuk Lee, Daehyun Baek, Youngil Koh, Sung Soo Yoon, Young-Joon Kim, Jong-Hee Chae, Woong-Yang Park, Jong Hwa Bhak, Murim Choi
A database of 5305 healthy Korean individuals reveals genetic and clinical implications for an East Asian population. Experimental & molecular medicine 54 (11) (2022)
Woo Kyung Chung, Inyoung Hwang, Byungwook Kim, Jihyun Jung, Kyung-Sang Yu, In-Jin Jang, Jaeseong Oh
pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers. Clinical and translational science (2022)
Joo Young Na, Deok Yong Yoon, Hyounggyoon Yoo, Seung Hwan Lee, Kyung-Sang Yu, In-Jin Jang, Sang-Ku Yoo, Youngah Kim, Jaeseong Oh
Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first-in-class, first-in-human study. Clinical and translational science 15 (11) (2022)
Woo Kyung Chung, Inyoung Hwang, Byungwook Kim, Jihyun Jung, Kyung-Sang Yu, In-Jin Jang, Jaeseong Oh
Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers. Clinical and translational science (2022)
Sejung Hwang, Soyoung Lee, Eunwoo Kim, Inyoung Hwang, Joo-Youn Cho, Jae-Young Chung, In-Jin Jang, Jaeseong Oh
The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjects. Clinical and translational science 15 (9) (2022)
Sang Hwan Ji, Ki Young Huh, Jaeseong Oh, Hee-Jeong Jeong, Young Eun Jang, Eun Hee Kim, Ji-Hyun Lee, Jin-Tae Kim, Hee Soo Kim
Reversal of rocuronium-induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis. Clinical and translational science (2022)
Jihyun Jung, Soyoung Lee, Jaeseong Oh, Seung Hwan Lee, In-Jin Jang, Donghwan Lee, Kyung-Sang Yu
Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects. Translational and clinical pharmacology 29 (1) (2021)
Ki Young Huh, Sejung Hwang, Sang Yeob Park, Hye Jung Lim, Miryung Jin, Jaeseong Oh, Kyung Sang Yu, Jae Yong Chung
Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib. Pharmaceutics 13 (5) (2021)
JuYeun Jeon, Jaeseong Oh, Kyung-Sang Yu
A meta-analysis: efficacy and safety of anti-epileptic drugs prescribed in Korea as monotherapy and adjunctive treatment for patients with focal epilepsy. Translational and clinical pharmacology 29 (1) (2021)
Jihyun Kang, Andrew HyoungJin Kim, Inseung Jeon, Jaeseong Oh, In-Jin Jang, Seung Hwan Lee, Joo-Youn Cho
Endogenous metabolic markers for predicting the activity of dihydropyrimidine dehydrogenase. Clinical and translational science (2021)
Byungwook Kim, Deok Yong Yoon, Seung Hwan Lee, In-Jin Jang, Kyung-Sang Yu, Joo-Youn Cho, Jaeseong Oh
Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform. Translational and clinical pharmacology 29 (3) (2021)
Xuanyou Jin, Jaeseong Oh, Joo-Youn Cho, SeungHwan Lee, Su Jin Rhee
Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease. Antibiotics (Basel, Switzerland) 9 (11) (2020)
Jung Sunwoo, Sang Chun Ji, Jaeseong Oh, Mu Seong Ban, Ji Yeon Nam, Bongtae Kim, Geun Seog Song, Kyung-Sang Yu, In-Jin Jang, Seung Hwan Lee
Pharmacodynamics of tegoprazan and revaprazan after single and multiple oral doses in healthy subjects. Alimentary pharmacology & therapeutics 52 (11-12) (2020)
Bo Rim Kim, Jaeseong Oh, Kyung-Sang Yu, Ho Geol Ryu
Pharmacokinetics of human antithrombin III concentrate in the immediate postoperative period after liver transplantation. British journal of clinical pharmacology 86 (5) (2020)
Mu Seong Ban, Yu-Kyong Kim, Byungwook Kim, Jina Jung, Yong-Il Kim, Jaeseong Oh, Kyung-Sang Yu
Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteers. Translational and clinical pharmacology 28 (4) (2020)
Jaeseong Oh, Ki Young Huh, Young-Gyu Cho, Ji-Eun Cha, Se-Jin Kim, Seo Hyun Yoon, Sung Sup Park, Hyunyee Yoon, Jieon Lee, Howard Lee
Safety, tolerability and pharmacokinetics and pharmacodynamics of HL2351, a novel hybrid fc-fused interleukin-1 receptor antagonist, in healthy subjects: A first-in-human study. British journal of clinical pharmacology 86 (2) (2020)
Jung Sunwoo, Jaeseong Oh, S J Moon, S C Ji, S H Lee, K-S Yu, H S Kim, A Lee, I-J Jang
Safety, tolerability, pharmacodynamics and pharmacokinetics of DWP14012, a novel potassium-competitive acid blocker, in healthy male subjects. Alimentary pharmacology & therapeutics 48 (2) (2018)
Sunny Park, Yang Jin Hyun, Yu Ran Kim, Ju Hyun Lee, Sunae Ryu, Jeong Mi Kim, Woo Yong Oh, Han Sung Na, Jong-Gu Lee, Doo Won Seo, In Yeong Hwang, Zewon Park, In-Jin Jang, Jaeseong Oh, Seung Eun Choi
Effects of CYP2C19 Genetic Polymorphisms on PK/PD Responses of Omeprazole in Korean Healthy Volunteers. Journal of Korean medical science 32 (5) (2017)
Jaeseong Oh, SeungHwan Lee, Howard Lee, Joo-Youn Cho, Seo Hyun Yoon, In-Jin Jang, Kyung-Sang Yu, Kyoung Soo Lim
The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans. PloS one 12 (4) (2017)
Jaeseong Oh, SeungHwan Lee, Anhye Kim, Jangsoo Yoon, Kyungho Jang, Doo H Lee, Sunyoung Cho, Sang Rim Lee, Kyung-Sang Yu, Jae-Yong Chung
Safety, Tolerability, and Pharmacokinetic Characteristics of a Novel Nonopioid Analgesic, VVZ-149 Injections in Healthy Volunteers: A First-in-Class, First-in-Human Study. Journal of clinical pharmacology 58 (1) (2017)